ID   AAKB2_HUMAN             Reviewed;         272 AA.
AC   O43741; A8K9V5; B4DH06; Q5VXY0;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   12-APR-2017, entry version 164.
DE   RecName: Full=5'-AMP-activated protein kinase subunit beta-2;
DE            Short=AMPK subunit beta-2;
GN   Name=PRKAB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9575201; DOI=10.1074/jbc.273.20.12443;
RA   Thornton C., Snowden M.A., Carling D.;
RT   "Identification of a novel AMP-activated protein kinase beta subunit
RT   isoform that is highly expressed in skeletal muscle.";
RL   J. Biol. Chem. 273:12443-12450(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12490143; DOI=10.1006/mcpr.2002.0439;
RA   Prochazka M., Farook V.S., Ossowski V., Wolford J.K., Bogardus C.;
RT   "Variant screening of PRKAB2, a type 2 diabetes mellitus
RT   susceptibility candidate gene on 1q in Pima Indians.";
RL   Mol. Cell. Probes 16:421-427(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-184, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION BY ULK1 AND ULK2.
RX   PubMed=21460634; DOI=10.4161/auto.7.7.15451;
RA   Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M.,
RA   Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B.;
RT   "Ulk1-mediated phosphorylation of AMPK constitutes a negative
RT   regulatory feedback loop.";
RL   Autophagy 7:696-706(2011).
RN   [15]
RP   REVIEW ON FUNCTION.
RX   PubMed=17307971; DOI=10.1161/01.RES.0000256090.42690.05;
RA   Towler M.C., Hardie D.G.;
RT   "AMP-activated protein kinase in metabolic control and insulin
RT   signaling.";
RL   Circ. Res. 100:328-341(2007).
RN   [16]
RP   REVIEW ON FUNCTION.
RX   PubMed=17712357; DOI=10.1038/nrm2249;
RA   Hardie D.G.;
RT   "AMP-activated/SNF1 protein kinases: conserved guardians of cellular
RT   energy.";
RL   Nat. Rev. Mol. Cell Biol. 8:774-785(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-108; THR-148;
RP   SER-158 AND SER-170, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 187-272 IN COMPLEX WITH
RP   PRKAA1 AND PRKAG1.
RX   PubMed=17851531; DOI=10.1038/nature06161;
RA   Xiao B., Heath R., Saiu P., Leiper F.C., Leone P., Jing C.,
RA   Walker P.A., Haire L., Eccleston J.F., Davis C.T., Martin S.R.,
RA   Carling D., Gamblin S.J.;
RT   "Structural basis for AMP binding to mammalian AMP-activated protein
RT   kinase.";
RL   Nature 449:496-500(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) OF 187-272 IN COMPLEX WITH
RP   PRKAA1 AND PRKAG1, AND MUTAGENESIS OF HIS-235.
RX   PubMed=21399626; DOI=10.1038/nature09932;
RA   Xiao B., Sanders M.J., Underwood E., Heath R., Mayer F.V., Carmena D.,
RA   Jing C., Walker P.A., Eccleston J.F., Haire L.F., Saiu P.,
RA   Howell S.A., Aasland R., Martin S.R., Carling D., Gamblin S.J.;
RT   "Structure of mammalian AMPK and its regulation by ADP.";
RL   Nature 472:230-233(2011).
CC   -!- FUNCTION: Non-catalytic subunit of AMP-activated protein kinase
CC       (AMPK), an energy sensor protein kinase that plays a key role in
CC       regulating cellular energy metabolism. In response to reduction of
CC       intracellular ATP levels, AMPK activates energy-producing pathways
CC       and inhibits energy-consuming processes: inhibits protein,
CC       carbohydrate and lipid biosynthesis, as well as cell growth and
CC       proliferation. AMPK acts via direct phosphorylation of metabolic
CC       enzymes, and by longer-term effects via phosphorylation of
CC       transcription regulators. Also acts as a regulator of cellular
CC       polarity by remodeling the actin cytoskeleton; probably by
CC       indirectly activating myosin. Beta non-catalytic subunit acts as a
CC       scaffold on which the AMPK complex assembles, via its C-terminus
CC       that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1,
CC       PRKAG2 or PRKAG3).
CC   -!- SUBUNIT: AMPK is a heterotrimer of an alpha catalytic subunit
CC       (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-
CC       catalytic subunits (PRKAG1, PRKAG2 or PRKAG3).
CC       {ECO:0000269|PubMed:17851531, ECO:0000269|PubMed:21399626}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1053424, EBI-1053424;
CC       Q08117-2:AES; NbExp=4; IntAct=EBI-1053424, EBI-11741437;
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-1053424, EBI-744695;
CC       Q7L4P6:BEND5; NbExp=3; IntAct=EBI-1053424, EBI-724373;
CC       Q9H2G9:BLZF1; NbExp=6; IntAct=EBI-1053424, EBI-2548012;
CC       Q8IYA8:CCDC36; NbExp=5; IntAct=EBI-1053424, EBI-8638439;
CC       O14627:CDX4; NbExp=3; IntAct=EBI-1053424, EBI-10181162;
CC       Q96BA8:CREB3L1; NbExp=3; IntAct=EBI-1053424, EBI-6942903;
CC       O43186:CRX; NbExp=5; IntAct=EBI-1053424, EBI-748171;
CC       P14920:DAO; NbExp=4; IntAct=EBI-1053424, EBI-3908043;
CC       Q5VWN6-2:FAM208B; NbExp=3; IntAct=EBI-1053424, EBI-10172380;
CC       P15976:GATA1; NbExp=3; IntAct=EBI-1053424, EBI-3909284;
CC       P15976-2:GATA1; NbExp=4; IntAct=EBI-1053424, EBI-9090198;
CC       Q8WXI9:GATAD2B; NbExp=3; IntAct=EBI-1053424, EBI-923440;
CC       Q7L5D6:GET4; NbExp=6; IntAct=EBI-1053424, EBI-711823;
CC       A0A0C4DGS5:GOLGA2; NbExp=4; IntAct=EBI-1053424, EBI-11522202;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1053424, EBI-618309;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-1053424, EBI-745305;
CC       Q9UKT9:IKZF3; NbExp=8; IntAct=EBI-1053424, EBI-747204;
CC       Q9UIH9:KLF15; NbExp=5; IntAct=EBI-1053424, EBI-2796400;
CC       Q6A162:KRT40; NbExp=5; IntAct=EBI-1053424, EBI-10171697;
CC       P60370:KRTAP10-5; NbExp=3; IntAct=EBI-1053424, EBI-10172150;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-1053424, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-1053424, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=5; IntAct=EBI-1053424, EBI-10172052;
CC       Q9BQ66:KRTAP4-12; NbExp=3; IntAct=EBI-1053424, EBI-739863;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-1053424, EBI-10172511;
CC       P26371:KRTAP5-9; NbExp=5; IntAct=EBI-1053424, EBI-3958099;
CC       Q9BYQ4:KRTAP9-2; NbExp=7; IntAct=EBI-1053424, EBI-1044640;
CC       Q9BYQ2:KRTAP9-4; NbExp=3; IntAct=EBI-1053424, EBI-10185730;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-1053424, EBI-741037;
CC       Q9Y5V3:MAGED1; NbExp=3; IntAct=EBI-1053424, EBI-716006;
CC       Q99750:MDFI; NbExp=7; IntAct=EBI-1053424, EBI-724076;
CC       A4D127:MEOX2; NbExp=3; IntAct=EBI-1053424, EBI-10172134;
CC       O75928:PIAS2; NbExp=3; IntAct=EBI-1053424, EBI-348555;
CC       Q13131:PRKAA1; NbExp=12; IntAct=EBI-1053424, EBI-1181405;
CC       P54646:PRKAA2; NbExp=11; IntAct=EBI-1053424, EBI-1383852;
CC       P54619:PRKAG1; NbExp=10; IntAct=EBI-1053424, EBI-1181439;
CC       P61289:PSME3; NbExp=7; IntAct=EBI-1053424, EBI-355546;
CC       P11217:PYGM; NbExp=5; IntAct=EBI-1053424, EBI-357469;
CC       Q8TAI7:RHEBL1; NbExp=5; IntAct=EBI-1053424, EBI-746555;
CC       Q9UFD9:RIMBP3; NbExp=3; IntAct=EBI-1053424, EBI-10182375;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-1053424, EBI-742487;
CC       O75558:STX11; NbExp=3; IntAct=EBI-1053424, EBI-714135;
CC       Q8N4C7:STX19; NbExp=3; IntAct=EBI-1053424, EBI-8484990;
CC       Q12933:TRAF2; NbExp=6; IntAct=EBI-1053424, EBI-355744;
CC       Q5T124:UBXN11; NbExp=3; IntAct=EBI-1053424, EBI-746004;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43741-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43741-2; Sequence=VSP_055820, VSP_055821;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated when associated with the catalytic subunit
CC       (PRKAA1 or PRKAA2). Phosphorylated by ULK1 and ULK2; leading to
CC       negatively regulate AMPK activity and suggesting the existence of
CC       a regulatory feedback loop between ULK1, ULK2 and AMPK.
CC       {ECO:0000269|PubMed:21460634}.
CC   -!- SIMILARITY: Belongs to the 5'-AMP-activated protein kinase beta
CC       subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ224538; CAA12030.1; -; mRNA.
DR   EMBL; AF504543; AAM74153.1; -; Genomic_DNA.
DR   EMBL; AF504538; AAM74153.1; JOINED; Genomic_DNA.
DR   EMBL; AF504539; AAM74153.1; JOINED; Genomic_DNA.
DR   EMBL; AF504540; AAM74153.1; JOINED; Genomic_DNA.
DR   EMBL; AF504541; AAM74153.1; JOINED; Genomic_DNA.
DR   EMBL; AF504542; AAM74153.1; JOINED; Genomic_DNA.
DR   EMBL; AK292820; BAF85509.1; -; mRNA.
DR   EMBL; AK294863; BAG57967.1; -; mRNA.
DR   EMBL; AK316005; BAH14376.1; -; mRNA.
DR   EMBL; AL356378; CAH72644.1; -; Genomic_DNA.
DR   EMBL; CH471223; EAW50945.1; -; Genomic_DNA.
DR   EMBL; BC053610; AAH53610.1; -; mRNA.
DR   CCDS; CCDS925.1; -. [O43741-1]
DR   RefSeq; NP_005390.1; NM_005399.4. [O43741-1]
DR   UniGene; Hs.50732; -.
DR   PDB; 2F15; X-ray; 2.00 A; A=69-163.
DR   PDB; 2V8Q; X-ray; 2.10 A; B=187-272.
DR   PDB; 2V92; X-ray; 2.40 A; B=187-272.
DR   PDB; 2V9J; X-ray; 2.53 A; B=187-272.
DR   PDB; 2Y8L; X-ray; 2.50 A; B=187-272.
DR   PDB; 2Y8Q; X-ray; 2.80 A; B=187-270.
DR   PDB; 2YA3; X-ray; 2.51 A; B=187-272.
DR   PDB; 4CFH; X-ray; 3.24 A; B=187-272.
DR   PDB; 4EAI; X-ray; 2.28 A; B=189-272.
DR   PDB; 4EAJ; X-ray; 2.61 A; B=189-272.
DR   PDB; 4RER; X-ray; 4.05 A; B=76-272.
DR   PDB; 4REW; X-ray; 4.58 A; B=76-272.
DR   PDBsum; 2F15; -.
DR   PDBsum; 2V8Q; -.
DR   PDBsum; 2V92; -.
DR   PDBsum; 2V9J; -.
DR   PDBsum; 2Y8L; -.
DR   PDBsum; 2Y8Q; -.
DR   PDBsum; 2YA3; -.
DR   PDBsum; 4CFH; -.
DR   PDBsum; 4EAI; -.
DR   PDBsum; 4EAJ; -.
DR   PDBsum; 4RER; -.
DR   PDBsum; 4REW; -.
DR   ProteinModelPortal; O43741; -.
DR   SMR; O43741; -.
DR   BioGrid; 111552; 99.
DR   DIP; DIP-39763N; -.
DR   IntAct; O43741; 140.
DR   STRING; 9606.ENSP00000254101; -.
DR   ChEMBL; CHEMBL3038456; -.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   GuidetoPHARMACOLOGY; 1544; -.
DR   CAZy; CBM48; Carbohydrate-Binding Module Family 48.
DR   iPTMnet; O43741; -.
DR   PhosphoSitePlus; O43741; -.
DR   EPD; O43741; -.
DR   MaxQB; O43741; -.
DR   PaxDb; O43741; -.
DR   PeptideAtlas; O43741; -.
DR   PRIDE; O43741; -.
DR   DNASU; 5565; -.
DR   Ensembl; ENST00000254101; ENSP00000254101; ENSG00000131791. [O43741-1]
DR   GeneID; 5565; -.
DR   KEGG; hsa:5565; -.
DR   UCSC; uc001epe.5; human. [O43741-1]
DR   CTD; 5565; -.
DR   DisGeNET; 5565; -.
DR   GeneCards; PRKAB2; -.
DR   HGNC; HGNC:9379; PRKAB2.
DR   HPA; HPA044342; -.
DR   MIM; 602741; gene.
DR   neXtProt; NX_O43741; -.
DR   OpenTargets; ENSG00000131791; -.
DR   PharmGKB; PA33747; -.
DR   eggNOG; KOG1616; Eukaryota.
DR   eggNOG; ENOG410XRB3; LUCA.
DR   GeneTree; ENSGT00390000001416; -.
DR   HOGENOM; HOG000230597; -.
DR   HOVERGEN; HBG050430; -.
DR   KO; K07199; -.
DR   OMA; GERHGTK; -.
DR   OrthoDB; EOG091G0DZR; -.
DR   PhylomeDB; O43741; -.
DR   TreeFam; TF313827; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-163680; AMPK inhibits chREBP transcriptional activation activity.
DR   Reactome; R-HSA-200425; Import of palmitoyl-CoA into the mitochondrial matrix.
DR   Reactome; R-HSA-2151209; Activation of PPARGC1A (PGC-1alpha) by phosphorylation.
DR   Reactome; R-HSA-380972; Energy dependent regulation of mTOR by LKB1-AMPK.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   SignaLink; O43741; -.
DR   SIGNOR; O43741; -.
DR   ChiTaRS; PRKAB2; human.
DR   EvolutionaryTrace; O43741; -.
DR   GeneWiki; PRKAB2; -.
DR   GenomeRNAi; 5565; -.
DR   PRO; PR:O43741; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000131791; -.
DR   CleanEx; HS_PRKAB2; -.
DR   Genevisible; O43741; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0031588; C:nucleotide-activated protein kinase complex; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006853; P:carnitine shuttle; TAS:Reactome.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:Reactome.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0016236; P:macroautophagy; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:GOC.
DR   GO; GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0045859; P:regulation of protein kinase activity; IEA:InterPro.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR032640; AMPK1_CBM.
DR   InterPro; IPR030081; AMPK_beta-2.
DR   InterPro; IPR006828; ASC_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR10343:SF79; PTHR10343:SF79; 1.
DR   Pfam; PF16561; AMPK1_CBM; 1.
DR   Pfam; PF04739; AMPKBI; 1.
DR   SMART; SM01010; AMPKBI; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis;
KW   Lipid metabolism; Phosphoprotein; Reference proteome.
FT   CHAIN         1    272       5'-AMP-activated protein kinase subunit
FT                                beta-2.
FT                                /FTId=PRO_0000204368.
FT   MOD_RES      39     39       Phosphoserine; by ULK1.
FT                                {ECO:0000305|PubMed:21460634}.
FT   MOD_RES      40     40       Phosphothreonine; by ULK1.
FT                                {ECO:0000305|PubMed:21460634}.
FT   MOD_RES      69     69       Phosphoserine; by ULK1. {ECO:0000250}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     108    108       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     148    148       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     170    170       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     174    174       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZH4}.
FT   MOD_RES     184    184       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1     25       MGNTTSDRVSGERHGAKAARSEGAG -> MPRGRSTRSWWG
FT                                VRTTPACSASLTP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055820.
FT   VAR_SEQ      26    107       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055821.
FT   MUTAGEN     235    235       H->A: Results in an AMPK enzyme that is
FT                                activable by phosphorylation but has
FT                                significantly increased rate of
FT                                dephosphorylation in phosphatase assays.
FT                                {ECO:0000269|PubMed:21399626}.
FT   STRAND       76     83       {ECO:0000244|PDB:2F15}.
FT   STRAND       90     94       {ECO:0000244|PDB:2F15}.
FT   HELIX        95     97       {ECO:0000244|PDB:2F15}.
FT   STRAND      112    129       {ECO:0000244|PDB:2F15}.
FT   STRAND      132    134       {ECO:0000244|PDB:2F15}.
FT   STRAND      141    143       {ECO:0000244|PDB:2F15}.
FT   STRAND      149    155       {ECO:0000244|PDB:2F15}.
FT   TURN        159    162       {ECO:0000244|PDB:2F15}.
FT   STRAND      201    204       {ECO:0000244|PDB:2V8Q}.
FT   HELIX       210    213       {ECO:0000244|PDB:4CFH}.
FT   STRAND      214    217       {ECO:0000244|PDB:2V8Q}.
FT   TURN        236    239       {ECO:0000244|PDB:2V92}.
FT   STRAND      242    244       {ECO:0000244|PDB:4EAI}.
FT   STRAND      250    259       {ECO:0000244|PDB:2V8Q}.
FT   STRAND      262    271       {ECO:0000244|PDB:2V8Q}.
SQ   SEQUENCE   272 AA;  30302 MW;  42B23BD70B92519C CRC64;
     MGNTTSDRVS GERHGAKAAR SEGAGGHAPG KEHKIMVGST DDPSVFSLPD SKLPGDKEFV
     SWQQDLEDSV KPTQQARPTV IRWSEGGKEV FISGSFNNWS TKIPLIKSHN DFVAILDLPE
     GEHQYKFFVD GQWVHDPSEP VVTSQLGTIN NLIHVKKSDF EVFDALKLDS MESSETSCRD
     LSSSPPGPYG QEMYAFRSEE RFKSPPILPP HLLQVILNKD TNISCDPALL PEPNHVMLNH
     LYALSIKDSV MVLSATHRYK KKYVTTLLYK PI
//
